Patent Assignment
Reel/Frame 064197/0253
Assignment of Assignor's Interest
Recorded: 2023-07-10
Pages: 3
Assignor
TRIPHASE RESEARCH AND DEVELOPMENT III CORP.
Executed: 2023-05-17
Assignee
R.P. SCHERER TECHNOLOGIES, LLC
112 NORTH CURRY STREET, CARSON CITY, NEVADA, 89703
Covered Property
(1)
Anti-CD22 Antibody-Maytansine Conjugates, Combinations, and Methods of Use Thereof
Application:
16/216,233 →
Publication:
US 2019/0201541
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 27, 2019
From: MACLAREN, ANN
To: TRIPHASE ACCELERATOR U.S. CORPORATION
Reel/Frame 048712/0691 →
Assignment of Assignor's Interest
Apr 16, 2021
From: TRIPHASE ACCELERATOR U.S. CORPORATION
To: TRIPHASE RESEARCH AND DEVELOPMENT III CORP.
Reel/Frame 055944/0177 →
Assignment of Assignor's Interest
May 23, 2023
From: TRIPHASE RESEARCH AND DEVELOPMENT III CORP.
To: R.P. SCHERER TECHNOLOGIES, LLC
Reel/Frame 063740/0236 →
Security Interest
Dec 19, 2024
From: CATALENT CTS (KANSAS CITY), LLC; REDWOOD BIOSCIENCE, INC.; R.P. SCHERER TECHNOLOGIES, LLC; CATALENT WELLNESS, LLC
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 069743/0458 →